Regulatory T cells in cancer immunotherapy

Tanaka, Atsushi, Sakaguchi, Shimon·2017·Cell Research

Cited by (1,001)

Items 701–800 of 1,001

  1. Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer
    Mingjie Wang, Wenxiang Xue, Hanghang Yuan, Zhicheng Wang, Lei Yu · 2024 · International Journal of Nanomedicine
  2. Metabolic‐Immune Suppression Mediated by the SIRT1‐CX3CL1 Axis Induces Functional Enhancement of Regulatory T Cells in Colorectal Carcinoma
    Ruiyang Zi, Xiang Zhao, Limei Liu, Yijie Wang, Rui Zhang, Zhiheng Bian, Haoran Jiang, Taorui Liu, Yixin Sun, Han Peng et al. · 2025 · Advanced Science
  3. Treg regulation of the epithelial stem cell lineage
    Inchul Cho, Prudence PokWai Lui, Niwa Ali · 2020 · Journal of Immunology and Regenerative Medicine
  4. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma
    Ryosuke Jikuya, Takeshi Kishida, Masahiko Sakaguchi, Tomoyuki Yokose, Masato Yasui, Akihito Hashizume, Tomoyuki Tatenuma, Nobuhiko Mizuno, Kentaro Muraoka, Susumu Umemoto et al. · 2020 · Cancer Immunology Immunotherapy
  5. TRIM68, PIKFYVE, and DYNLL2: The Possible Novel Autophagy- and Immunity-Associated Gene Biomarkers for Osteosarcoma Prognosis
    Jie Jiang, Dachang Liu, Guoyong Xu, Tuo Liang, Chaojie Yu, Shian Liao, Liyi Chen, Shengsheng Huang, Xuhua Sun, Ming Yi et al. · 2021 · Frontiers in Oncology
  6. Immune function assessing of TIM3/CD28‐modified CD19 CAR‐T cells and general CD19 CAR‐T cells through a high‐throughput single‐cell microarray platform
    Chao Wang, Chunhua Wang, Huimin Liu, Songbo Zhao, Jiaoyan Qiu, Ping Li, Zhongqian Liu, Mingyuan Sun, Xiaowei Shao, Yihe Wang et al. · 2024 · Interdisciplinary medicine
  7. Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?
    Jinming Liu, Biao Zhang, Guolin Zhang, Dong Shang · 2024 · Frontiers in Immunology
  8. Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer
    Yuzhao Jin, Jin Fang Jiang, Wei Bo Mao, Minghua Bai, Qianping Chen, Ji Ye Zhu · 2024 · Cancer Letters
  9. Ultrasound-responsive metal–organic framework-based nanosystem for sonodynamic therapy/amplified ferroptosis/IDO-blockade osteosarcoma immunotherapy
    Qingjian Lei, Wei Zhou, Shijie Gao, Ningxiang Sun, Bo Wang, Haixia Yang, Jie Wang, Yu Zhao, Qing Chen, Jian Tian et al. · 2024 · Chemical Engineering Journal
  10. Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy
    Monika E. Ryba-Stanisławowska · 2024 · Cellular Oncology
  11. Unleashing the Power of immune Checkpoints: A new strategy for enhancing Treg cells depletion to boost antitumor immunity
    Guoxin Li, Siqi Li, Yi Jiang, Tao Chen, Zhengwen An · 2025 · International Immunopharmacology
  12. Shaping the battlefield: EGFR and KRAS tumor mutations’ role on the immune microenvironment and immunotherapy responses in lung cancer
    Bassel Alsaed, Nina Bobik, Hanna K. Laitinen, Tanvi Nandikonda, Ilkka Ilonen, Heidi M. Haikala · 2025 · Cancer and Metastasis Reviews
  13. Immunoliposomes bearing lymphocyte activation gene 3 fusion protein and P5 peptide: A novel vaccine for breast cancer
    Saeed Mohammadian Haftcheshmeh, Parvin Zamani, Mohammad Mashreghi, Amin Reza Nikpoor, Jalil Tavakkol‐Afshari, Mahmoud Reza Jaafari · 2020 · Biotechnology Progress
  14. Qa-1b Modulates Resistance to Anti–PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing
    Xiao Zhang, Erich Y. Sabio, Chirag Krishna, Xiaoxiao Ma, Jingming Wang, Hui Jiang, Jonathan J. Havel, Timothy An-thy Chan · 2021 · Molecular Cancer Research
  15. Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
    Diego J. Laderach, Daniel Compagno · 2021 · Cancers
  16. Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
    Jung‐Soo Pyo, Byoung Kwan Son, Hyo Young Lee, Il Hwan Oh, Kwang Hyun Chung · 2021 · Current Oncology
  17. AMP-activated protein kinase alpha1 promotes tumor development via FOXP3 elevation in tumor-infiltrating Treg cells
    Junqing An, Ye Ding, Changjiang Yu, Jian Li, Shaojin You, Zhixue Liu, Ping Song, Ming‐Hui Zou · 2021 · iScience
  18. Histone deacetylase 6 plays an important role in TGF-β-induced murine Treg cell differentiation by regulating cell proliferation
    Ji Hyeon Lee, Hyeong Su Kim, Sung Woong Jang, Gap Ryol Lee · 2022 · Scientific Reports
  19. The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
    Nurul Hakimah Mohd Salim, Ali Mussa, Naveed Ahmed, Suhana Ahmad, Chan Yean Yean, Rosline Hassan, Vuk Uskoković, Rohimah Mohamud, Nur Asyilla Che Jalil · 2023 · Biomedicines
  20. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration
    Xiaomin Chen, Shunfeng Hu, Yang Han, Yiqing Cai, Tiange Lu, Xinting Hu, Yurou Chu, Xiangxiang Zhou, Xin Wang · 2023 · Clinical and Experimental Medicine
  21. M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironment
    Misato Ito, Kosaku Mimura, Shotaro Nakajima, Hirokazu Okayama, Katsuharu Saito, Takahiro Nakajima, Tomohiro Kikuchi, Hisashi Onozawa, Shotaro Fujita, Wataru Sakamoto et al. · 2023 · Cancer Immunology Immunotherapy
  22. Distant antimetastatic effect of enterotropic colon cancer–derived α4β7 + CD8 + T cells
    Virginie Féliu, Carlos Gomez‐Roca, Marie Michelas, Noémie Thébault, Françoise Lauzéral-Vizcaïno, Anna Salvioni, Lise Scandella, Émeline Sarot, Carine Valle, Camille-Charlotte Balança et al. · 2023 · Science Immunology
  23. Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy
    Ahmad Alzamami · 2023 · Medical Oncology
  24. Why Y matters? The implication of loss of Y chromosome in blood and cancer
    Ying Wang, Soichi Sano · 2024 · Cancer Science
  25. Priming immunity via herbal components and their nanomedicines for the treatment of cancer
    Xiang Li, Chenkai Gong, Abid Naeem, Jing Liu, Ming Yang, Jing Zhang, Hongming Shang · 2024 · Acupuncture and Herbal Medicine
  26. Immunosuppressive JAG2 + tumor‐associated neutrophils hamper PD‐1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells
    Chenyang Wang, Moran Yang, Yujing Zhong, Kankan Cao, Xueling Wang, Chen Zhang, Yiying Wang, Mengdi He, Jiaqi Lu, Guodong Zhang et al. · 2025 · 癌症:英文版
  27. Tumour-infiltrating lymphocyte therapy landscape: prospects and challenges
    Ruqin Chen, Jeffrey E. Johnson, Ali Rezazadeh Roudkoli, Arkadiusz Zbigniew Dudek · 2025 · BMJ Oncology
  28. Immunological landscape of colorectal cancer: tumor microenvironment, cellular players and immunotherapeutic opportunities
    Adile Buse Andac-Aktas, Gizem Calibasi‐Kocal · 2025 · Frontiers in Molecular Biosciences
  29. S100‐stained perineural invasion is associated with worse prognosis in stage I/II colorectal cancer: Its possible association with immunosuppression in the tumor
    Yumiko Fukuda, Yoshihiro Tanaka, Ken Eto, Natsuko Ukai, Shoko Sonobe, Hiroyuki Takahashi, Masahiro Ikegami, Masayuki Shimoda · 2022 · Pathology International
  30. Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy
    Ronglin Wang, Yongdong Guo, Peixiang Ma, Yang Song, Jie Min, Ting Zhao, Lei Hua, Chao Zhang, Cheng Yang, Jingjie Shi et al. · 2022 · Frontiers in Oncology
  31. Viewing keloids within the immune microenvironment.
    Mengjie Shan, Youbin Wang · 2022 · PubMed Central
  32. Synthetic and Biodegradable Molybdenum(IV) Diselenide Triggers the Cascade Photo‐ and Immunotherapy of Tumor
    Jiulong Zhao, Yao Zhang, Jing Zhang, Hang Wu, Jinfeng Li, Yizhou Zhao, Liying Zhang, Duowu Zou, Zhao‐Shen Li, Shige Wang · 2022 · Advanced Healthcare Materials
  33. Stimuli-responsive hydrogels for cancer immunotherapy
    Jinlong Qin, Min Sun, Wei Hua Hu, Jiajing Cheng, Zhen Fan, Jianzhong Du · 2023 · Polymer Chemistry
  34. The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer
    Ali Mussa, Hafeez Abiola Afolabi, Nazmul Huda Syed, Mustafa Talib, Ahmad Hafiz Murtadha, Khalid Hajissa, Noor Fatmawati Mokhtar, Rohimah Mohamud, Rosline Hassan · 2023 · Biomedicines
  35. PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer
    Chun Wu, Lian-Hui Duan, Hong-Mu Li, Xuefei Liu, Tao-Nong Cai, Yang Yang, Yuting Yin, W. Chang, Le-Qi Zhong, Lin Zhang et al. · 2023 · Clinical and Translational Medicine
  36. Cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent tumor recurrence
    Ju Chen, Bhaskara Reddy Madina, Elham Ahmadi, Timur Olegovich Yarovinsky, Marie Marthe Krady, Eileen Victoria Meehan, Isabella China Wang, Xiaoyang Ye, Elise Pitmon, Xianyong Ma et al. · 2023 · Acta Pharmaceutica Sinica B
  37. A dual-enzyme-like photosensitive nanozyme for remodeling the tumor immunosuppressive microenvironment to enhance immunotherapy
    Jiahao Zheng, Wangyang Meng, Zepeng Cui, Jia He Tian, Weian Zhang · 2024 · Biomaterials
  38. Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
    Maryam Jama, Yasser Tabana, Khaled Barakat · 2024 · European journal of medical research
  39. The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?
    Farid Ghorbaninezhad, Mina Afrashteh Nour, Omid Rahbar Farzam, Hossein Saeedi, Ahmad Ghorbani Vanan, Mohammad Bakhshivand, Mahdi Jafarlou, Amirhossein Hatami‐Sadr, Behzad Baradaran · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  40. Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences
    Diwakar Davar, Nathan Bahary · 2018 · Targeted Oncology
  41. Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection
    Camila Mareti Bonin, Cacilda Tezelli Junqueira Padovani, Izaías Pereira da Costa, Leandro S. Ávila, Alda Maria Teixeira Ferreira, Carlos Eurico Fernandes, Andrielli Rodrigues dos Santos, Inês Aparecida Tozetti · 2018 · Journal of Medical Virology
  42. Dissecting the Mechanisms of Intestinal Immune Homeostasis by Analyzing T-Cell Immune Response in Crohn's Disease and Colorectal Cancer
    Tianming Jiang, Jie Zheng, Nana Li, Xiaodong Li, Jixing He, Junde Zhou, Boshi Sun, Qiang Chi · 2024 · Current Gene Therapy
  43. Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies
    Suman Giri, Gopal Lamichhane, Jitendra Pandey, Ramesh Khadayat, Sindhu KC, Hari Prasad Devkota, Dipendra Khadka · 2025 · International Journal of Molecular Sciences
  44. Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities
    Man Wang, Yuanzhuo Zhao, Ke Xu, Chao Liu, Hui Zhong, You Wu, Ke Zhang, Shanzhai Wei · 2025 · Frontiers in Immunology
  45. Expanding the frontier of CAR therapy: comparative insights into CAR-T, CAR-NK, CAR-M, and CAR-DC approaches
    Yiling Zhang, Rong Hu, Xiaoling Xie, Yuhua Li · 2025 · Annals of Hematology
  46. Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors
    Manny D. Bacolod, Francis Barany, Karsten A. Pilones, Paul B. Fisher, Romulo de Castro · 2019 · Advances in cancer research
  47. The Role of CD28 and CD8+ T Cells in Keloid Development
    Mengjie Shan, Hao Liu, Yan Hao, Kexin Song, Cheng Feng, Youbin Wang · 2022 · International Journal of Molecular Sciences
  48. Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation
    Ginette S. Santiago-Sánchez, James W. Hodge, Kellsye P. Fabian · 2022 · Frontiers in Immunology
  49. The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma
    Chia Yuen Chong, Michelle Goh, Sandro Virgilio Porceddu, Danny Rischin, Annette May Ling Lim · 2022 · American Journal of Clinical Dermatology
  50. Antitumor mechanism of cannabidiol hidden behind cancer hallmarks
    Chaobiao Yan, Yu Li, Hanqing Liu, Diyu Chen, Jian Wu · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  51. Discovery of ICOS‐Targeted Small Molecules Using Pharmacophore‐Based Screening
    Laura Calvo‐Barreiro, Valerij Talagayev, Szymon Pach, Somaya A. Abdel‐Rahman, Gerhard Wolber, Moustafa Tarek Gabr · 2023 · ChemMedChem
  52. Neutrophil Extracellular Trap is Surrogate Biomarker for Prognosis and Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
    Wentao Zhong, Qianyu Wang, Xiaofei Shen, Yuan Lv, Liang Sun, Ran An, Hongyan Zhu, Huiyun Cai, Gang Chen, Aijun Liu et al. · 2023 · Journal of Inflammation Research
  53. Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma
    Qi Huang, Xin Zhong, Jing Li, Rui Hu, Jinyu Yi, Jialing Sun, Youhua Xu, Xiaozhou Zhou · 2024 · Biomedicine & Pharmacotherapy
  54. KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axis
    Qing-Xiao Liu, Yue Zhu, Hongmei Yi, Yige Shen, Li Wang, Shu Cheng, Pengpeng Xu, Haimin Xu, Luting Zhou, Yao‐Hui Huang et al. · 2024 · International Journal of Biological Sciences
  55. A comprehensive review of the roles of T-cell immunity in preeclampsia
    Peng Xu, Ibeh Chinwe Oluchi-Amaka, Joanne Y-H Kwak-Kim, Xiuhua Yang · 2025 · Frontiers in Immunology
  56. FOXP3 and Its Cofactors as Targets of Immunotherapies
    Yasuhiro Nagai, Lian Lam, Mark Irwin Greene, Hongtao Zhang · 2019 · Engineering
  57. Target the Host, Kill the Bug; Targeting Host Respiratory Immunosuppressive Responses as a Novel Strategy to Improve Bacterial Clearance During Lung Infection
    Alanna M. Kelly, Rachel M. McLoughlin · 2020 · Frontiers in Immunology
  58. Immune suppression by human thymus-derived effector Tregs relies on glucose/lactate-fueled fatty acid synthesis
    Sander de Kivit, Mark Mensink, Sarantos Kostidis, Rico J. E. Derks, Esther A. Zaal, Marieke Heijink, Lotte J. Verleng, Evert de Vries, Ellen Schrama, Niek Blomberg et al. · 2024 · Cell Reports
  59. Combinational CAR T-cell therapy for solid tumors: Requisites, rationales, and trials
    Kyohei Misawa, Hina Bhat, Prasad S. Adusumilli, Zhaohua Hou · 2024 · Pharmacology & Therapeutics
  60. Ketogenic diet modulates immune cell transcriptional landscape and ameliorates experimental autoimmune uveitis in mice
    Runping Duan, Tianfu Wang, Zhaohuai Li, Loujing Jiang, Xiaoyang Yu, Daquan He, Tianyu Tao, Xiuxing Liu, Zhaohao Huang, Lei Feng et al. · 2024 · Journal of Neuroinflammation
  61. Nutrient acquisition of gut microbiota: Implications for tumor immunity
    Yusha Wang, Jing Huang, Huan Tong, Yuting Jiang, Jiang Yu, Xuelei Ma · 2025 · Seminars in Cancer Biology
  62. Challenges and strategies in clinical applications of CAR-T therapy for autoimmune diseases
    Xiaomei Chen, Kaifan Liu, Bowen Liu, Shiyin Li, Yulian Wang, Xin Du, Jianyu Weng, Bing Song, Kongming Wu, Peilong Lai · 2025 · Journal of Hematology & Oncology
  63. Melanoma: Prognostic Factors and Factors Predictive of Response to Therapy
    Martina Strudel, Lucia Festino, Vito Vanella, Massimiliano Beretta, Francesco Maria Marincola, Paolo A. Ascierto · 2019 · Current Medicinal Chemistry
  64. Blood microparticles are a component of immune modulation in red blood cell transfusion
    Marion Klea Pinheiro, Marie Tamagne, Rahma Elayeb, Muriel Andrieu, France Pirenne, Benoît Vingert · 2020 · European Journal of Immunology
  65. Distribution of mucosal PD-1 expressing T cells in patients with colitis of different etiologies
    Britt Roosenboom, Carmen S. Horjus Talabur Horje, Carolijn Smids, Jan Willem Leeuwis, Elly van Koolwijk, Marcel J. M. Groenen, Peter J. Wahab, Ellen G. van Lochem · 2021 · Scandinavian Journal of Gastroenterology
  66. Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma
    Natalia García‐Sancha, Roberto Corchado‐Cobos, Lorena Bellido-Hernández, Concepción Román‐Curto, Esther Cardeñoso Álvarez, Jesús Pérez‐Losada, Alberto Órfão, Javier Cañueto · 2021 · Cancers
  67. Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects
    Sarah‐Jane Leigh, Caoimhe M. K. Lynch, Brian Bird, Brendan T. Griffin, John F. Cryan, Gerard A. Clarke · 2022 · Expert Opinion on Drug Metabolism & Toxicology
  68. The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer
    Jakub Dobroch, Klaudia Bojczuk, Adrian Kołakowski, Marta Baczewska, Paweł Knapp · 2022 · Molecules
  69. HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity
    Andrew Nguyen, Louisa Ho, Richard A. Hogg, Lan Chen, Scott R. Walsh, Yonghong Wan · 2022 · Journal of Clinical Investigation
  70. Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
    Mengying Cui, Xing Yi, Zhenzhen Cao, Danxia Zhu, Jun Wu · 2022 · Journal of Oncology
  71. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment
    Zhongji Jiang, Wei Zhang, Zhipeng Zeng, Donge Tang, Chujiao Li, Wanxia Cai, Yumei Chen, Ya Li, Jin Qiu, Xinzhou Zhang et al. · 2022 · Frontiers in Immunology
  72. Mechanisms of primary and acquired resistance to immune checkpoint inhibitors in advanced non–small cell lung cancer: A multiplex immunohistochemistry–based single-cell analysis
    Kohsuke Isomoto, Koji Haratani, Takahiro Tsujikawa, Yusuke Makutani, Hisato Kawakami, Masayuki Takeda, Kimio Yonesaka, Kaoru Tanaka, Tsutomu Iwasa, Hidetoshi Hayashi et al. · 2022 · Lung Cancer
  73. EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities
    Heydari, Zahra, Peshkova, Maria, Gonen, Zeynep Burcin, Coretchi, Ianos, Eken, Ahmet, Yay, Arzu Hanım, Dogan, Muhammet Ensar, Gokce, Nuriye, Akalin, Hilal, Kosheleva, Nastasia et al. · 2023 · Journal of Molecular Medicine
  74. Mesenchymal stem cells can prevent or promote the progression of colon cancer based on their timing of administration
    Weiqian Hu, Weijun Wang, Xin Jiang, Zeyu Wang, Rong Lin · 2023 · Journal of Translational Medicine
  75. The role of lipid metabolism in cancer radioresistance
    Dandan An, Danyi Zhai, Chao Wan, Kunyu Yang · 2023 · Clinical & Translational Oncology
  76. Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy
    Yifan Liu, Hongying Wang, Xinyu Zhao, Jiashen Zhang, Zhiling Zhao, Xia Lian, Juan Zhang, Feng Kong, Tao Hu, Ting Wang et al. · 2023 · Cancer Research
  77. Foxp3-mediated blockage of ryanodine receptor 2 underlies contact-based suppression by regulatory T cells
    Xiaobo Wang, Shuang Geng, Junchen Meng, Ning Kang, Xin-Yi Liu, Yanni Xu, Huiyun Lyu, Ying Xu, Xun Xu, Xinrong Song et al. · 2023 · Journal of Clinical Investigation
  78. Neoantigen sequestrated autophagosomes as therapeutic cancer vaccines
    Jinxie Zhang, Jiahui Cao, Liuchang Wang, Sitong Li, Fanqiang Meng, Xin Liang, Hanyu Jiang, Ran Luo, Dunwan Zhu, Fan Zhang et al. · 2024 · Journal of Controlled Release
  79. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer
    Liyan Lao, Siting Fan, Erwei Song · 2017 · Advances in experimental medicine and biology
  80. Cell-mediated immune resistance in cancer
    Yuhao Wang, Emily Hays, Martina Rama, Benjamin Bonavida · 2019 · Cancer Drug Resistance
  81. Adoptive CD8 + T-cell grafted with liposomal immunotherapy drugs to counteract the immune suppressive tumor microenvironment and enhance therapy for melanoma
    Simeng Liu, Huimin Liu, Xiaoshuang Song, Ai‐Ling Jiang, Yuchuan Deng, Chengli Yang, Dan Sun, Kun Jiang, Fan Yang, Yu Zheng · 2021 · Nanoscale
  82. The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density
    Sören Schnellhardt, Johannes Hirneth, Maike J. Büttner-Herold, Christoph Daniel, Marlen Haderlein, Arndt Hartmann, Rainer Fietkau, Luitpold Valentin Distel · 2022 · Frontiers in Immunology
  83. A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli
    Yinci Zhang, Xinkuang Liu, Amin Li, Xiaolong Tang · 2022 · PLoS ONE
  84. HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer
    Wenjing Zhang, Zhijuan Lin, Fuyan Shi, Qiang Wang, Yujia Kong, Yanfeng Ren, Juncheng Lyu, Chao Sheng, Yuting Li, Hao Qin et al. · 2022 · Cancers
  85. The state of T cells before cryopreservation: Effects on post-thaw proliferation and function
    Ying Luo, Peng Wang, Hui Liu, Zhengyan Zhu, Chenglong Li, Yingtang Gao · 2017 · Cryobiology
  86. T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin
    Corinne Bauer, Ashik Ahmed Abdul Pari, Viktor Umansky, Jochen Sven Utikal, Petra Boukamp, Hellmut G. Augustin, Sergij Goerdt, Cyrill Géraud, Moritz Felcht · 2018 · Cancer Immunology Immunotherapy
  87. Multidimensional immune profiling in Gastric Cancer Multiplex Immunohistochemistry Atlas from Peking University Cancer Hospital project informs PD-1/PD-L1 blockade efficacy
    Keren Jia, Yang Chen, Yi Xie, Xiaoyi Chong, Yilin Li, Yingcheng Charles Wu, Jiajia Yuan, Yanyan Li, Xujiao Feng, Yajie Hu et al. · 2023 · European Journal of Cancer
  88. Tregs from human blood differentiate into nonlymphoid tissue–resident effector cells upon TNFR2 costimulation
    Mark Mensink, Lotte J. Verleng, Ellen Schrama, George M.C. Janssen, Rayman T.N. Tjokrodirijo, Peter A. van Veelen, Qinyue Jiang, María Fernanda Pascutti, Marie‐Louise van der Hoorn, Michael Eikmans et al. · 2024 · JCI Insight
  89. Tumour Microenvironment: The General Principles of Pathogenesis and Implications in Diffuse Large B Cell Lymphoma
    Stanislavs Sinkarevs, Boriss Štrumfs, Svetlana Volkova, Ilze Štrumfa · 2024 · Cells
  90. Single cell suppression profiling of human regulatory T cells
    Jonas Nørskov Søndergaard, Janyerkye Tulyeu, David Priest, Shimon Sakaguchi, James B. Wing · 2025 · Nature Communications
  91. Effective Predictor of Colorectal Cancer Survival Based on Exclusive Expression Pattern Among Different Immune Cell Infiltration
    Xiaowen Xu, Jun Ma, Guanyu Yu, Qun Qiu, Wei Zhang, Fuao Cao · 2021 · Journal of Histochemistry & Cytochemistry
  92. HPV-mediated Cervical Cancer: A Systematic Review on Immunological Basis, Molecular Biology, and Immune Evasion Mechanisms
    Kumpati Premkumar, Vanajothi Ramar, Natarajan Srikanth, Rajendran Vijayakumar, Mathivathana Palanisamy, Sundaresan Bhavaniramya · 2021 · Current Drug Targets
  93. Targeting protein kinases benefits cancer immunotherapy
    Zhengkun Zhang, Lang Bu, Junhang Luo, Jianping Guo · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  94. Tumor cell-derived microparticles packaging monocarboxylate transporter4 inhibitor fluvastatin suppress lung adenocarcinoma via tumor microenvironment remodeling and improve chemotherapy
    Wenjuan Chen, Qi Tan, Mengfei Guo, Tingting Liao, Yumei Li, Zhengrong Yin, E. Zhou, Jingjing Deng, Minglei Li, Zimo Yang et al. · 2022 · Chemical Engineering Journal
  95. Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucose
    Takashi Maruyama, Hirofumi Miyazaki, Yun-Ji Lim, Jian Gu, Masaki Ishikawa, Taichi Yoshida, WanJun Chen, Yuji Owada, Hiroyuki Shibata · 2023 · Frontiers in Immunology
  96. The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers
    Gujie Wu, Hefei Ren, Qin Hu, Huiyun Ma, Hongyu Chen, Lin Zhou, Kun Xu, Liang Ding · 2023 · Frontiers in Immunology
  97. Focus on T cell exhaustion: new advances in traditional Chinese medicine in infection and cancer
    Shenghao Li, Liyuan Hao, Junli Zhang, Jiali Deng, Xiaoyu Hu · 2023 · Chinese Medicine
  98. N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer
    Mingqi Wang, Jiajie Zhu, Yingquan Ye, Ping Li, Weijie Sun, Mei Zhang · 2023 · Aging
  99. A Trojan Horse Delivery Vehicle Carrying siRNA Nanotherapeutics with Multiple Tumor Microenvironment Responsiveness Elicits Robust Antitumor Immune Responses In Situ via a “Self‐Synergistic” Approach
    Yan Fang, Shuai Chen, Mingyi Zhang, Xiaojie Lin, Xuechao Jin, Mingming Zhang, Yunmeng Liu, Yaxin Wang, Kai Shi · 2023 · Advanced Healthcare Materials
  100. LncRNA-edited biomimetic nanovaccines combined with anti-TIM-3 for augmented immune checkpoint blockade immunotherapy
    Yang Zhang, Feng Liu, Lulu Tan, Xin Li, Zheng Dai, Qian Cheng, Jia Shuo Liu, Yang Wang, Lei Haley Huang, Lin Wang et al. · 2023 · Journal of Controlled Release